Back to Search Start Over

436P Phase Ib/II study of the polo-like kinase 1 (PLK1) inhibitor, onvansertib, in combination with FOLFIRI and bevacizumab for second line treatment of KRAS-mutated metastatic colorectal cancer

Authors :
H. J. Lenz
Mark Erlander
Afsaneh Barzi
Errin Samuelsz
Maya Ridinger
Daniel H. Ahn
T. S. Bekaii-Saab
Source :
Annals of Oncology. 31:S427
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Details

ISSN :
09237534
Volume :
31
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........4e6e5d938514067ad9f97e8d2abe9ae2
Full Text :
https://doi.org/10.1016/j.annonc.2020.08.547